- Q1 2024 Zymeworks Inc Earnings Call TranscriptMay 02, 2024$9 (+2.74%)Earnings
- Q4 2023 Zymeworks Inc Earnings Call TranscriptMar 06, 2024$12.23 (+2.09%)Earnings
- Zymeworks Inc at Citi Virtual Oncology Leadership Summit TranscriptFeb 22, 2024
- Zymeworks Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Zymeworks Inc Earnings Call TranscriptNov 07, 2023$7.37 (+1.24%)Earnings
- Zymeworks Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Zymeworks Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Zymeworks Inc Earnings Call TranscriptAug 10, 2023$7.76 (+0.78%)Earnings
- Zymeworks Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Zymeworks Inc Earnings Call TranscriptMay 08, 2023$8.76 (+1.39%)Earnings
- Zymeworks Inc Investor Call TranscriptApr 18, 2023
- Zymeworks Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Zymeworks Inc Earnings Call TranscriptMar 07, 2023$7.96 (+0.13%)Earnings
- Zymeworks Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Zymeworks Inc HERIZON-BTC-01 Top-Line Results Call TranscriptDec 19, 2022
Q3 2023 Zymeworks Inc Earnings Call Transcript
Good day and thank you for standing by. Welcome to the Zymeworks Third Quarter 2023 Results Conference Call. (Operator Instructions) Please be advised today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Shrinal Inamdar, Director of Investor Relations. Please go ahead.
Thank you, operator. Good afternoon, everyone. My name is Shrinal Inamdar, Director of Investor Relations here at Zymeworks and I like to welcome you to our third quarter 2023 results conference call. Slide 2, before we begin, I'd like to remind you that we will be making a number of forward-looking statements during this call, including without limitation those forward-looking statements identified in our presentation slides and the accompanying oral commentary. Forward-looking statements are based upon our current expectations and various assumptions and are subject to the usual risks and uncertainties associated with companies in our industry and at our stage of development.
For discussion of these risk and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)